diff --git a/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md b/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md new file mode 100644 index 00000000..f324b9f7 --- /dev/null +++ b/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md @@ -0,0 +1,27 @@ +--- +type: claim +domain: health +description: "Despite decades of effective generic antihypertensives, BP control rates among treated patients reached only 23.4% in 2021-2023, and simultaneous control of hypertension, diabetes, and hyperlipidemia never exceeded 30% from 1999-2023" +confidence: proven +source: JACC longitudinal study 1999-2023, NHANES nationally representative data +created: 2026-03-30 +attribution: + extractor: + - handle: "vida" + sourcer: + - handle: "jacc-study-authors" + context: "JACC longitudinal study 1999-2023, NHANES nationally representative data" +--- + +# Only 23 percent of treated US hypertensives achieve blood pressure control demonstrating pharmacological availability is not the binding constraint in cardiometabolic disease management + +The JACC study tracking 1999-2023 NHANES data reveals a striking failure mode in US cardiometabolic disease management. Among patients already receiving treatment for hypertension, only 23.4% (95% CI: 21.5%-25.2%) achieved blood pressure control by 2021-2023 criteria. More dramatically, the proportion of individuals with all three conditions (hypertension, diabetes, hyperlipidemia) achieving simultaneous control never exceeded 30% at any point during the 24-year study period, despite all three conditions having effective, affordable generic medications available throughout this timeframe (antihypertensives since 1980s, statins since late 1990s, metformin since decades prior). The study explicitly notes that 'treatment and control of these conditions improved during the 2000s, but progress has plateaued in subsequent years,' indicating this is not a problem of insufficient time for diffusion. This 76.6% treatment failure rate among patients already prescribed medication demonstrates that the binding constraint is not drug availability, efficacy, or cost, but rather the behavioral, social, and structural factors that determine medication adherence, lifestyle modification, and care continuity. The plateau in control rates despite continued awareness campaigns and clinical guideline updates suggests these non-pharmacological barriers are not being addressed by the current healthcare delivery model. + +--- + +Relevant Notes: +- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] +- [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] + +Topics: +- [[_map]] diff --git a/inbox/queue/2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023.md b/inbox/queue/2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023.md index 2e1a9d2d..fad5ca76 100644 --- a/inbox/queue/2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023.md +++ b/inbox/queue/2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023.md @@ -7,9 +7,13 @@ date: 2025-10-01 domain: health secondary_domains: [] format: journal-article -status: unprocessed +status: processed priority: high tags: [hypertension, treatment-adherence, control-rates, cardiometabolic, diabetes, hyperlipidemia, United-States, SDOH, behavioral-health, JACC] +processed_by: vida +processed_date: 2026-03-30 +claims_extracted: ["only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content @@ -55,3 +59,12 @@ Despite the availability of effective generic medications for all three conditio PRIMARY CONNECTION: [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] WHY ARCHIVED: Provides the clinical-operational evidence for Belief 2 — drugs that work are not achieving outcomes at population level. The 23.4% control rate is the single most striking number for the "medicine fails despite availability" argument. EXTRACTION HINT: Extract as a claim about cardiometabolic risk factor control failure, explicitly framing the 23.4% control rate as evidence that behavioral/SDOH barriers overwhelm pharmacological availability. Extract alongside the hypertension mortality doubling claim (queue/2026-03-30-jacc-cvd-mortality-trends-1999-2023.md) — they form a cause/effect pair. + + +## Key Facts +- Hypertension affects 1 in 2 US adults under 2017 ACC/AHA criteria +- Hypertension prevalence: 23.4% ages 18-39, 52.5% ages 40-59, 71.6% ages 60+ +- Hypertension prevalence showed little change between 2009 and 2023 +- Among treated hypertensive patients, only 23.4% (95% CI: 21.5%-25.2%) achieved BP control in 2021-2023 +- Simultaneous control of hypertension, diabetes, and hyperlipidemia never exceeded 30% between 1999-2023 +- Treatment and control rates improved during 2000s but plateaued in subsequent years